BioSpace News Archive

FDA

FDA Approves Noven Pharmaceuticals’ Transdermal Patch for Schizophrenia

The patch is a once-per-day treatment that provides sustained concentrations of Secuado (asenapine), an atypical antipsychotic drug used to treat schizophrenia.

October 15, 2019
·
2 min read
·
Alex Keown
Business

Helping Cancer Patients Navigate Clinical Trials

While trials may be listed online in readily accessible databases, it can be hard to know what to search for and how to make sense of the medical jargon of the listings.

October 15, 2019
·
7 min read
·
Chelsea Weidman Burke
UCD Researcher wins US-Ireland grant for personalised nutrition project with Harvard and QUB

Professor Lorraine Brennan from University College Dublin is delighted to have been awarded a US-Ireland grant, funded by the Health Research Board (HRB), to the tune of almost €1 million.

October 15, 2019
·
1 min read
Genetown

CELLINK is awarded Entrepreneur of the Year in Sweden 2019

Last Friday, CELLINK and its four co-founders were awarded the prestigious award, Entrepreneur of the Year in Sweden, 2019.

October 15, 2019
·
1 min read
Drug Development

Anatara’s gut-targeted dietary supplement completes preclinical testing, demonstrating it can treat inflammatory gastrointestinal disease and may promote mucosal healing

Successful completion of the preclinical program has provided strong scientific proof that the GaRP dietary supplement has the potential to be game changing

October 15, 2019
·
3 min read
Business

GeoVax Presenting at Upcoming October 2019 European Scientific Conferences

GeoVax Labs, Inc. announced that it will be represented during presentations at the following upcoming European scientific conferences.

October 15, 2019
·
3 min read
Business

Magnetic Insight Announces the Appointment of David Panzarella as Chief Commercial Officer

Magnetic Insight, Inc., the leader in Magnetic Particle Imaging solutions, announced that David Panzarella has been appointed as the company’s Chief Commercial Officer.

October 15, 2019
·
2 min read
Clinigen launches Managed Access Program for Progenics Pharmaceuticals for AZEDRA® outside the US

Clinigen Group plc has launched a Managed Access Program for Progenics Pharmaceuticals, Inc., an oncology company developing innovative targeted medicines and artificial intelligence to find, fight and follow cancer, to provide AZEDRA® via a global Managed Access Program, outside the United States.

October 15, 2019
·
3 min read
Drug Development

MGB Biopharma Announces Promising Phase IIa Clinical Trial Update for MGB-BP-3, a Novel, Potent Bactericidal Antibiotic Targeting Clostridium difficile-Associated Diarrhoea (CDAD)

MGB Biopharma, a biopharmaceutical company developing a novel class of anti-infectives to address the major global problem of antibiotic resistance, announces an update on progress in its Phase IIa clinical study.

October 15, 2019
·
4 min read
Seventure Partners Life Sciences Corporate Update Health for Life: July 2019 – September 2019

Seventure Partners, one of Europe’s leaders in financing innovation and a world-leader in life science microbiome investment, is pleased to provide an update on its Health for Life investments for the period July 2019 to September 2019.

October 15, 2019
·
9 min read